Literature DB >> 10937167

"Dual pathology" and the significance of surgical outcome in "Dostoewsky's epilepsy".

C L Vera1, S J Patel, W Naso.   

Abstract

A patient with a right occipital arterio-venous malformation (AVM) and seizures heralded by "lights", and experiencing "ecstasy" underwent a right occipital lobectomy after the AVM was embolized. Thereafter, seizures began with motor arrest and lip smacking, but never again with "light and ecstasy". A right temporal lobectomy and electrocorticogram (E.Co.G) were performed under local anesthesia four years after occipital lobectomy. Abundant spiking activity was recorded from the right hippocampus which showed gliosis and neuronal loss in the pathology studies. Electrical stimulation of the lateral and basal temporal cortices failed to elicit the vision of "lights" or the experience of "ecstasy". The patient has had two seizures in the last two years as a result of a lapse in taking his anti-convulsant medication. He now lives alone, seizure-free. The possible abnormally induced functional network organization and structures involved in the production of the "ecstasy" phenomenon are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10937167

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  3 in total

1.  Ecstatic Epileptic Seizures: A Glimpse into the Multiple Roles of the Insula.

Authors:  Markus Gschwind; Fabienne Picard
Journal:  Front Behav Neurosci       Date:  2016-02-17       Impact factor: 3.558

2.  Ecstatic and gelastic seizures relate to the hypothalamus.

Authors:  Kenney Roy Roodakker; Bisrat Ezra; Helena Gauffin; Francesco Latini; Maria Zetterling; Shala Berntsson; Anne-Marie Landtblom
Journal:  Epilepsy Behav Rep       Date:  2020-03-21

3.  Ecstatic and gelastic seizures related to the hypothalamus.

Authors:  Kenney Roy Roodakker; Bisrat Ezra; Helena Gauffin; Francesco Latini; Maria Zetterling; Shala Berntsson; Anne-Marie Landtblom
Journal:  Epilepsy Behav Rep       Date:  2020-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.